Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

Nasdaq plunged over 2% as Middle East tensions rattled Wall Street

View original at seekingalpha.com
Nasdaq plunged over 2% as Middle East tensions rattled Wall Street [Showing Business Investment Options on a Digital Computer Screen] HStocks Wall Street’s major market averages closed lower on Friday as U.S…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The reported U.S. proposal to end the conflict is one-sided and unfair

    60% confidence

  • The S&P 500 breaking below 6,500 suggests stocks want to go lower and may be headed towards a 10% correction at 6,280. This may be one of the most attractive entry points for new money since Liberation Day.

    60% confidence

  • The semiconductor sector had a less bad week than the S&P or the Nasdaq, closing well above the lows put in the week of 9 March. The indices all made new cycle lows today. The reversal, when it comes, will be violent, but there will be time to catch it when it happens. Patience is the name of this game.

    60% confidence

  • Talks with Tehran are going very well

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Nasdaq plunged over 2% as Middle East tensions rattled Wall Street — Source | Via News | ViaNews Market